Skip to main content
SpringerLink
Log in

Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Sodium selenate, administered intraperitoneally (i.p.), resulted in an improvement in glucose tolerance in treated diabetic rats. Fed rat plasma glucose levels were reduced by selenate treatment in streptozotocin diabetic rats. The lowest values of blood glucose were reached within 3 weeks of beginning the treatment. Food and fluid consumption was reduced in treated compared to untreated diabetic rats. Diabetic treated rats did not release insulin in response to a glucose challenge and insulin release in response to a challenge was markedly reduced in control treated rats. Assessment of heart function using a working heart apparatus showed that treated diabetic rats with improved blood glucose levels had normal heart function at 8 weeks of diabetes in contrast to hearts from non-treated diabetics. This study extends previous observations on the in vivo insulin-like effects of sodium selenate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ezaki O: The insulin-like effects of sodium selenate in rat adipocytes. J Biol Chem 265: 1124–28, 1990

    Google Scholar 

  2. McNeill JH, Delgatty HLM, Battell ML: Insulinlike effects of sodium selenate in streptozotocin diabetic rats. Diabetes 40: 1675–78, 1991

    Google Scholar 

  3. Becker DJ, Reul B, Ozcelikay AT, Buchet JP, Henquin J-C, Brichard SM: Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia 39: 3–11, 1996

    Google Scholar 

  4. Ghosh R, Mukherjee B, Chatterjee M: A novel effect of selenium on streptozotocin-induced diabetic mice. Diabetes Res 25: 165–171, 1994

    Google Scholar 

  5. Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474–1477, 1985

    Google Scholar 

  6. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH: Oral vanadyl sulphate in treatment of diabetes mellitus in rats. Am J Physiol 257: H904–H911, 1989

    Google Scholar 

  7. Ramanadham S, Brownsey RW, Cros GH, Mongold JJ, McNeill JH: Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment. Metabolism 38: 1022–1028, 1989

    Google Scholar 

  8. Strout HV, Vicario PP, Biswas C, Saperstein R, Brady EJ, Pilch PF, Berger J: Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle. Endocrinology 126: 2728–2732, 1990

    Google Scholar 

  9. Brichard SM, Okitolonda W, Henquin JC: Long term improvement in glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048–2053,1988

    Google Scholar 

  10. Meyerovitch J, Farfel Z, Sack J, Shechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J Biol Chem 262: 6658–6662, 1987

    Google Scholar 

  11. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG: Selenium: biochemical role as a component of glutathione peroxidase. Science 179: 588–590, 1973

    Google Scholar 

  12. World Health Organization: Selenium Environmental Health Criteria 58: World Health Organization Geneva, 1987

    Google Scholar 

  13. Chen X, Yang G, Chen J, Chen X, Wen Z, Ge X: Studies on the relations of selenium and Keshan disease. Biol Trace Elem Res 2: 91–107, 1980

    Google Scholar 

  14. Hawkes WC, Wilhelmsen EC, Tappel AL: Abundance and tissue distribution of selenocystine-containing proteins in the rat. J Inorg Biochem 23: 77–92, 1985

    Google Scholar 

  15. Behne D Kyriakopoulos A Meinhold H Kohrle J: Identification of type 1 iodothyronine 5′-deiodinase as a selenoenzyme. Biochem Biophys Res Comm 173: 1143–1149, 1990

    Google Scholar 

  16. Behne D Kyriakopoulos A: Effects of dietary selenium on the tissue concentrations of type 1 iodothyronine 5′-deiodinase and other selenoproteins. Am J Clin Nutr Suppl 57: 310S–312S, 1993

    Google Scholar 

  17. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors. The Framingham Study. Circulation 59: 8–13, 1979

    Google Scholar 

  18. Opie LH: Effect of fatty acid on contractility and rhythm of the heart. Nature (London) 227: 1055–1066, 1970

    Google Scholar 

  19. Skipp JC, Menahan LA, Crass III MF, Chaudhuri SN: Heart triglycerides in health and disease. In: NS Dhalla (ed). Recent Advances in Studies on Cardiac Structure and Metabolism. Vol 3., University Park Press, Baltimore, MD, 1973, pp 179–204

    Google Scholar 

  20. Vadlamudi RVSV, Rodgers RL, McNeill JH: The effect of chronic alloxan-and streptozotocin-induced diabetes on isolated rat heart performance. Can J Physiol Pharmacol 60: 902–911, 1982

    Google Scholar 

  21. Tahiliani AG, Vadlamudi RVSV, McNeill JH: Prevention and reversal of altered myocardial function in diabetic rats by insulin treatment. Can J Physiol Pharmacol 61: 516–523, 1983

    Google Scholar 

  22. Turan B, Dalay N, Afrasyap L, Delilbasi E, Sengun Z, Sayal A, Isimer A: The effects of selenium supplementation on antioxidative enzyme activities and plasma and erythrocyte selenium levels. Acta Physiol Hung 81: 87–93, 1993

    Google Scholar 

  23. Zhong G-G, Jiang Y, Li ZB, Zhang BG, Zhang WJ, Yue G: Protective action of selenium and manganese on xanthine and xanthine oxidase induced oxidative damage to cultured heart cells. Chin Med J 103: 735–742.1990

    Google Scholar 

  24. Halverson AW, Palmer IS, Guss PL: Toxicity of selenium to post weanling rats. Toxicol Appl Pharmacol 9: 477–484, 1966

    Google Scholar 

  25. Tinsley IJ, Harr JR, Bone JF, Weswig PH, Yamamoto RS: Selenium toxicity in rats. I. Growth and longevity. In: OH Muth, JE Oldfield and PH Weswig (eds). Selenium in Biomedicine. The Avi Publishing Co. Inc., Westport, Conn., 1967, pp 141–152

    Google Scholar 

  26. Jacobs MM, Forst C: Toxicological effects of sodium selenite in Sprague Dawley rats. J Toxicol Environ Health 8: 575–585, 1981

    Google Scholar 

  27. Franke KW, Moxon AL: A comparison of the minimum fatal dose of selenium, tellurium, arsenic, and vanadium. J Pharmacol Exp Ther 58: 454–459, 1936

    Google Scholar 

  28. Schroeder HA Mitchener M: Selenium and tellurium in rats: effects on growth, survival, and tumors. J Nutr 101: 1531–1540, 1971

    Google Scholar 

  29. Smith MI, Westfall BB, Stohlman EF Jr: The elimination of selenium and its distribution in the tissues. U.S. Publ Health Rep 52: 1171–1177, 1937

    Google Scholar 

  30. Thorlacius-Ussing O: Selenium induced growth retardation. Histochemical and endocrinological studies on the anterior pituitaries of selenium treated rats. Danish Med Bull 37: 347–358, 1990

    Google Scholar 

  31. Tolman EI, Barris E, Burns M, Pansini R, Partridge R: Effects of vanadium on glucose metabolism in vitro. Life Sci 25: 1159–1165, 1979

    Google Scholar 

  32. Furnsinn C, Leitner G, Roden M, Osterode W, Waldhausl W: Improved glucose tolerance by acute vanadate but not selenate exposure in genetically obese rats (fa/fa). Intern J Obesity 19: 458–463, 1995

    Google Scholar 

  33. Tamura S, Brown TA, Dubler RE, Larner J: Insulin-like effects of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 dalton subunit of insulin receptor. Biochem Biophys Res Comm 113: 80–86, 1983

    Google Scholar 

  34. Shisheva A Shechter Y: Role of cytosolic tyrosine kinase in mediating insulinlike actions of vanadate in rat adipocytes. J Biol Chem 268: 6463–6469, 1993

    Google Scholar 

  35. Rodrigues BB, McNeill JH: Cardiac function in spontaneously hypertensive diabetic rats. Am J Physiol 251: H571–H580, 1986

    Google Scholar 

  36. Rodrigues BB, Goyal RK, McNeill JH: Effects of hydralazine on streptozotocin induced diabetic rats: Prevention of hyperlipidemia and improvement in cardiac function. J Pharmacol Exp Ther 237: 292– 299, 1986

    Google Scholar 

  37. Koehler H, Peters H-J, Pankau H, Duck H-J: Selenium in cardiology and angiology. Biol Trace Elem Res 15: 157–167, 1988

    Google Scholar 

  38. Konz K-H, Haap M, Hill KE, Burk RF, Walsh RA: Diastolic dysfunction of perfused rat hearts induced by hydrogen peroxide. Protective effect of selenium. J Mol Cell Cardiol 21: 789–795, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada

    Mary L. Battell, Heather L.M. Delgatty & John H. McNeill

Authors
  1. Mary L. Battell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heather L.M. Delgatty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John H. McNeill
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Battell, M.L., Delgatty, H.L. & McNeill, J.H. Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats. Mol Cell Biochem 179, 27–34 (1998). https://doi.org/10.1023/A:1006819227506

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006819227506

Search

Navigation